Clinical Trial Update: TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for the TEMPO study evaluating trimethoprim-sulfamethoxazole in granulomatosis with polyangiitis, a Phase 1/2 study currently not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis

Drugs mentioned

• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: University of Pennsylvania | Conditions: Granulomatosis With Polyangiitis, Wegener Granulomatosis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING